XML 27 R16.htm IDEA: XBRL DOCUMENT
v3.22.1

Stockholders' Equity | 3 Months Ended
--- | ---
Mar. 31, 2022
Stockholders' Equity |
Stockholders' Equity | 9. Stockholders’ Equity Common Stock Dividends ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended
​ | ​ | March 31,
​ |  | 2022 |  | 2021
Dividends declared per common share | ​ | $ | 0.64 |  | $ | 0.56
​ Reconciliation of Outstanding Common Shares ​
​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended
​ | ​ | March 31,
​ |  | 2022 |  | 2021
​ | ​ | (in millions)
Beginning balance |  | 261.7 |  | 273.3
Shares issued |  | 1.7 |  | 1.4
Treasury stock acquired |  | (11.2) |  | (2.2)
Ending balance |  | 252.2 |  | 272.5
​ In February 2020, our Board of Directors (“Board”) authorized a share repurchase program of up to $900.0 million of our outstanding common stock, which was completed in November 2021. In June 2021, our Board authorized a share repurchase program of up to $1.2 billion of our outstanding common stock, which has no expiration date. In January 2022, our Board authorized a $1.6 billion increase to the June 2021 share repurchase program authorization, which has no expiration date. Shares repurchased under these programs are accounted for as treasury stock, carried at cost and reflected as a reduction to stockholders’ equity. In March 2022, we entered into an accelerated share repurchase program with a third party financial institution to repurchase $700.0 million of common stock. We received approximately 8.5 million shares at an initial cost of $560.0 million from our counterparty as of March 31, 2022, which was recorded in treasury stock. The associated $140.0 million forward contract was recorded in additional paid-in capital. This program is scheduled to terminate no later than June 30, 2022, at which time we will settle any positive or negative share balances based on the daily volume-weighted average price of our common stock during the term of the program. There is no cap on the share price as the stock price increases, so we may have to provide consideration at the settlement date. The consideration could be settled in either cash or shares at our option, with a share cap of 21.4 million shares. As of March 31, 2022, when accounting for the previously mentioned $700.0 million accelerated share repurchase program, we had approximately $1.8 billion remaining on our current share repurchase authorizations. Other Comprehensive Loss ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended
​ | ​ | March 31, 2022
​ |  | Pre-Tax |  | Tax |  | After-Tax
​ | ​ | (in millions)
Net unrealized losses on available-for-sale securities during the period | ​ | $ | (5,542.9) | ​ | $ | 1,175.1 | ​ | $ | (4,367.8)
Reclassification adjustment for gains included in net income (1) | ​ |  | (40.6) | ​ | ​ | 5.2 | ​ | ​ | (35.4)
Adjustments for assumed changes in amortization patterns | ​ |  | 344.9 | ​ | ​ | (72.4) | ​ | ​ | 272.5
Adjustments for assumed changes in policyholder liabilities | ​ |  | 575.6 | ​ | ​ | (118.8) | ​ | ​ | 456.8
Net unrealized losses on available-for-sale securities | ​ |  | (4,663.0) | ​ | ​ | 989.1 | ​ | ​ | (3,673.9)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net unrealized losses on derivative instruments during the period | ​ |  | (21.0) | ​ | ​ | 4.4 | ​ | ​ | (16.6)
Reclassification adjustment for gains included in net income (2) | ​ |  | (6.8) | ​ | ​ | 1.4 | ​ | ​ | (5.4)
Adjustments for assumed changes in amortization patterns | ​ |  | 2.3 | ​ | ​ | (0.5) | ​ | ​ | 1.8
Adjustments for assumed changes in policyholder liabilities | ​ |  | 5.0 | ​ | ​ | (1.1) | ​ | ​ | 3.9
Net unrealized losses on derivative instruments | ​ | ​ | (20.5) | ​ | ​ | 4.2 | ​ | ​ | (16.3)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Foreign currency translation adjustment | ​ | ​ | 154.9 | ​ | ​ | (1.5) | ​ | ​ | 153.4
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Amortization of amounts included in net periodic benefit cost (3) | ​ |  | 9.0 | ​ | ​ | (2.3) | ​ | ​ | 6.7
Net unrecognized postretirement benefit obligation | ​ |  | 9.0 | ​ | ​ | (2.3) | ​ | ​ | 6.7
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Other comprehensive loss | ​ | $ | (4,519.6) | ​ | $ | 989.5 | ​ | $ | (3,530.1)
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended
​ | ​ | March 31, 2021
​ |  | Pre-Tax |  | Tax |  | After-Tax
​ | ​ | (in millions)
Net unrealized losses on available-for-sale securities during the period | ​ | $ | (3,276.7) | ​ | $ | 700.5 | ​ | $ | (2,576.2)
Reclassification adjustment for gains included in net income (1) | ​ |  | (27.4) | ​ |  | 5.7 | ​ |  | (21.7)
Adjustments for assumed changes in amortization patterns | ​ |  | 144.6 | ​ |  | (30.4) | ​ |  | 114.2
Adjustments for assumed changes in policyholder liabilities | ​ |  | 1,415.3 | ​ |  | (305.0) | ​ |  | 1,110.3
Net unrealized losses on available-for-sale securities | ​ |  | (1,744.2) | ​ |  | 370.8 | ​ |  | (1,373.4)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Net unrealized gains on derivative instruments during the period | ​ |  | 0.7 | ​ |  | (0.1) | ​ |  | 0.6
Reclassification adjustment for gains included in net income (2) | ​ |  | (4.4) | ​ |  | 0.9 | ​ |  | (3.5)
Adjustments for assumed changes in policyholder liabilities | ​ |  | 1.0 | ​ |  | (0.3) | ​ |  | 0.7
Net unrealized losses on derivative instruments | ​ |  | (2.7) | ​ |  | 0.5 | ​ |  | (2.2)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Foreign currency translation adjustment | ​ | ​ | (56.1) | ​ | ​ | (0.1) | ​ | ​ | (56.2)
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Unrecognized postretirement benefit obligation during the period | ​ | ​ | (9.1) | ​ | ​ | 1.9 | ​ | ​ | (7.2)
Amortization of amounts included in net periodic benefit cost (3) | ​ |  | 13.0 | ​ |  | (3.5) | ​ |  | 9.5
Net unrecognized postretirement benefit obligation | ​ |  | 3.9 | ​ |  | (1.6) | ​ |  | 2.3
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Other comprehensive loss | ​ | $ | (1,799.1) | ​ | $ | 369.6 | ​ | $ | (1,429.5)
(1) | Pre-tax reclassification adjustments relating to available-for-sale securities are reported in net realized capital gains (losses) on the consolidated statements of operations.
(2) | See Note 4, Derivative Financial Instruments, under the caption “Effect of Fair Value and Cash Flow Hedges on Consolidated Statements of Operations” for further details.
(3) | Amount is comprised of amortization of prior service cost (benefit) and recognized net actuarial (gain) loss, which is reported in operating expenses on the consolidated statements of operations. See Note 7, Employee and Agent Benefits, under the caption “Components of Net Periodic Benefit Cost” for further details.
Accumulated Other Comprehensive Income (Loss) ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Net unrealized | ​ | Net unrealized | ​ | Foreign | ​ | Unrecognized | ​ | Accumulated
​ | ​ | gains (losses) on | ​ | gains | ​ | currency | ​ | postretirement | ​ | other
​ | ​ | available-for-sale | ​ | on derivative | ​ | translation | ​ | benefit | ​ | comprehensive
​ |  | securities (1) |  | instruments |  | adjustment |  | obligation |  | income (loss)
​ | ​ | (in millions)
Balances as of January 1, 2021 | ​ | $ | 4,138.3 | ​ | $ | 18.2 | ​ | $ | (1,312.9) | ​ | $ | (460.5) | ​ | $ | 2,383.1
Other comprehensive loss during the period, net of adjustments | ​ |  | (1,351.7) | ​ | ​ | 1.3 | ​ | ​ | (56.0) | ​ | ​ | (7.2) | ​ | ​ | (1,413.6)
Amounts reclassified to AOCI | ​ |  | (21.7) | ​ | ​ | (3.5) | ​ | ​ | — | ​ | ​ | 9.5 | ​ | ​ | (15.7)
Other comprehensive loss | ​ |  | (1,373.4) | ​ | ​ | (2.2) | ​ | ​ | (56.0) | ​ | ​ | 2.3 | ​ | ​ | (1,429.3)
Balances as of March 31, 2021 | ​ | $ | 2,764.9 | ​ | $ | 16.0 | ​ | $ | (1,368.9) | ​ | $ | (458.2) | ​ | $ | 953.8
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Balances as of January 1, 2022 | ​ | $ | 3,467.4 | ​ | $ | 51.8 | ​ | $ | (1,563.6) | ​ | $ | (344.7) | ​ | $ | 1,610.9
Other comprehensive loss during the period, net of adjustments | ​ |  | (3,638.5) | ​ | ​ | (10.9) | ​ | ​ | 152.0 | ​ | ​ | — | ​ | ​ | (3,497.4)
Amounts reclassified to AOCI | ​ |  | (35.4) | ​ | ​ | (5.4) | ​ | ​ | — | ​ | ​ | 6.7 | ​ | ​ | (34.1)
Other comprehensive loss | ​ |  | (3,673.9) | ​ | ​ | (16.3) | ​ | ​ | 152.0 | ​ | ​ | 6.7 | ​ | ​ | (3,531.5)
Balances as of March 31, 2022 | ​ | $ | (206.5) | ​ | $ | 35.5 | ​ | $ | (1,411.6) | ​ | $ | (338.0) | ​ | $ | (1,920.6)
(1) | Net unrealized gains (losses) on available-for-sale securities for which an allowance for credit loss has been recorded were $6.2 million and $(2.4) million as of March 31, 2022 and 2021, respectively.
Noncontrolling Interest Interests held by unaffiliated parties in consolidated entities are reflected in noncontrolling interest, which represents the noncontrolling partners’ share of the underlying net assets of our consolidated subsidiaries. Noncontrolling interest that is not redeemable is reported in the equity section of the consolidated statements of financial position. The noncontrolling interest holders in certain of our consolidated entities maintain an equity interest that is redeemable at the option of the holder, which may be exercised on varying dates. Since redemption of the noncontrolling interest is outside of our control, this interest is excluded from stockholders’ equity and reported separately as redeemable noncontrolling interest on the consolidated statements of financial position. Our redeemable noncontrolling interest primarily relates to consolidated sponsored investment funds for which interests are redeemed at fair value from the net assets of the funds. For our redeemable noncontrolling interest related to other consolidated subsidiaries, redemptions are required to be purchased at fair value or a value based on a formula that management intended to reasonably approximate fair value based on a fixed multiple of earnings over a measurement period. The carrying value of the redeemable noncontrolling interest is compared to the redemption value at each reporting period. Any adjustments to the carrying amount of the redeemable noncontrolling interest for changes in redemption value prior to exercise of the redemption option are determined after the attribution of net income or loss of the subsidiary and are recognized in the redemption value as they occur. Adjustments to the carrying value of redeemable noncontrolling interest result in adjustments to additional paid-in capital and/or retained earnings. Adjustments are recorded in retained earnings to the extent the redemption value of the redeemable noncontrolling interest exceeds its fair value and will impact the numerator in our earnings per share calculations. All other adjustments to the redeemable noncontrolling interest are recorded in additional paid-in capital. Following is a reconciliation of the changes in the redeemable noncontrolling interest (in millions): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended
​ | ​ | March 31,
​ | ​ | 2022 | ​ | 2021
​ | ​ | (in millions)
Balance at beginning of period | ​ | $ | 332.5 | ​ | $ | 255.6
Net loss attributable to redeemable noncontrolling interest | ​ | ​ | (10.3) | ​ | ​ | (1.8)
Contributions from redeemable noncontrolling interest | ​ | ​ | 24.0 | ​ | ​ | 17.8
Distributions to redeemable noncontrolling interest | ​ | ​ | (39.6) | ​ | ​ | (16.3)
Change in redemption value of redeemable noncontrolling interest | ​ | ​ | 0.1 | ​ | ​ | 8.2
Other comprehensive income attributable to redeemable noncontrolling interest | ​ | ​ | 0.1 | ​ | ​ | —
Balance at end of period | ​ | $ | 306.8 | ​ | $ | 263.5
​

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (g) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644 Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (h) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 18 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 16 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration